Phase 1 trial of PINTA 745 in patients with prostate cancer
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2015
At a glance
- Drugs PINTA 745 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Amgen
- 20 Mar 2015 New trial record
- 26 Feb 2015 Results published in The Journal of Clinical Endocrinology and Metabolism in 2014, according to Form 10-K submitted for 2014 SEC filing.
- 26 Feb 2015 Results published in Form 10-K submitted for 2014 SEC filing.